IntelGenx to Report Third Quarter 2016 Financial Results on November 10, 2016

IntelGenx to Report Third Quarter 2016 Financial Results on November 10, 2016

ID: 504066

(firmenpresse) - SAINT-LAURENT, QUEBEC -- (Marketwired) -- 11/01/16 -- IntelGenx Technologies Corp., (TSX VENTURE: IGX)(OTCQX: IGXT), today announced that it will release its third quarter 2016 results for the period ended September 30, 2016, on November 10, 2016 at the close of the financial markets.

An accompanying conference call will be hosted by Dr. Horst G. Zerbe, President and Chief Executive Officer and Mr. Andre Godin, Executive Vice-President and Chief Financial Officer, to discuss the results and provide a business update. Details of the conference call and webcast are below:

Following the live call, a replay will be available on the Company's website, , under "Investor Relations".

About IntelGenx:

IntelGenx is a leading oral drug delivery company focused on the development and manufacturing of innovative pharmaceutical oral films based on its proprietary VersaFilm™ technology platform. Established in 2003, the Montreal-based company is listed on the TSX-V and OTC-QX.

IntelGenx highly skilled team provides comprehensive pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. IntelGenx state-of-the art manufacturing facility, established for the VersaFilm™ technology platform, supports lab-scale to pilot and commercial-scale production, offering full service capabilities to our clients. More information is available about the company at: .

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange), nor the OTCQX accepts responsibility for the adequacy or accuracy of this release.

Source: IntelGenx Technologies Corp.



Contacts:
Edward Miller
Director, IR and Corporate Communications
IntelGenx Corp.
+1 514-331-7440 (ext. 217)



Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Get Your Flu Shot at London Drugs and Help Protect the World's Most Vulnerable Children from Vaccine-Preventable Diseases Ogilvy CommonHealth Worldwide's Matt Giegerich named to MM&M's and PRWeek's
Bereitgestellt von Benutzer: Marketwired
Datum: 01.11.2016 - 13:00 Uhr
Sprache: Deutsch
News-ID 504066
Anzahl Zeichen: 0

contact information:
Town:

SAINT-LAURENT, QUEBEC



Kategorie:

Health & Nutrition



Diese Pressemitteilung wurde bisher 278 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"IntelGenx to Report Third Quarter 2016 Financial Results on November 10, 2016"
steht unter der journalistisch-redaktionellen Verantwortung von

IntelGenx Technologies Corp. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

IntelGenx Reports Third Quarter 2017 Financial Results ...

SAINT-LAURENT, QUEBEC -- (Marketwired) -- 11/09/17 -- IntelGenx Technologies Corp. (TSX VENTURE: IGX)(OTCQX: IGXT) (the "Company" or "IntelGenx") today reported financial results for the third quarter ended September 30, 2017. A ...

Alle Meldungen von IntelGenx Technologies Corp.



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z